Winnipeg-based Company claimed to be fraudulent, as it had publicised its ability to improve multiple sclerosis.

Lee Chuckry, 47 is one among the patients questioning the research and credentials. He has been living with MS for nearly two decades.
“MS just keeps progressing, that’s what it does. Hopefully I could stop it. That was my ultimate goal,” Chuckry said in an interview with CTV News.
His efforts led him to Regenetek, and it’s CEO: Doug Broeska. For $35,000, Regenetek patients were flown to India for the procedure. Chuckry was one of the participants. But when he returned home, he says his symptoms worsened.
In testimonials, MS patients attributed miraculous medical improvement to experimental stem cell therapy.
“I’m going to call Doug a con artist,” Chuckry said. “You are preying on people who are desperate. They are looking for hope of any sort."
Advertisements
None of the allegations have been proven in court, and Broeska has not been criminally charged. In a statement to CTV News, Regenetek wrote, “Its clinical study is being mischaracterized in the media.”
Advertisements
Source-Medindia